AdvanSix stock slips 2% on third quarter earnings miss

AdvanSix Inc. (ASIX) reported Q3 earnings that missed expectations, with an adjusted loss per share of -$0.24 vs. $0.28 estimate. Revenue was $430.81M, up 15% YoY. Stock fell 2% in pre-market trading. The company cited strong commercial execution and pricing strategies to offset inflation. Adjusted EBITDA declined to $14.6M, while cash flow improved to $48M. ASIX refinanced its credit facility and declared a $0.16 quarterly dividend.

Original reporting
Published Nov 4, 2026, 11:38 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ASIX
Bearish
high confidence
Mentioned
$ASIX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ASIXBearishHigh
01

Why it matters

The earnings miss highlights cost‑inflation pressures and may prompt analysts to lower forecasts.

02

Market read

The Q3 miss triggered a 2% pre‑market decline, indicating short‑term trading opportunity.

03

What to watch

Improved cash flow and new credit facility could support longer‑term stability.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

AdvanSix is a vertically integrated specialty chemicals producer that recently refinanced its credit facility.

Company-level read

Ticker impact

$ASIXBearishHigh confidence
Context

AdvanSix reported Q3 adjusted loss of $0.24 per share versus consensus loss of $0.28 and flat revenue, sending the stock down 2% pre‑market.

Expected impact

likely pressure as the market prices in the earnings miss and lower guidance expectations

Evidence & confidence

The surprise loss and flat revenue missed expectations, prompting a pre‑market sell‑off.

Market effects

Chemicals and specialty materials sector may see broader scrutiny after the miss.

U.S. small‑cap industrials could face short‑term weakness.

Limited to U.S. investors; no immediate global ripple.

Counterpoint

If the company can sustain 15% YoY sales growth, the dip may be overblown.

Key entities

  • Erin Kane

    President and CEO of AdvanSix who commented on the results.

Related articles

Med

AdvanSix Inc. Q3 2026 Earnings Call Summary

AdvanSix Inc. reported Q3 2026 earnings, highlighting 17% favorable pricing offsetting $65M raw material cost increases. The company maintained high operating rates, optimized production, and reduced fixed costs. It expects Q4 price-over-raws headwinds and a 2027 ammonium sulfate supply shortage. AdvanSix secured a $47M USDA grant for Project CENTURY and closed a $425M credit facility.

$ASIXMedAI 8/10

AdvanSix (ASIX) Q3 2026 Earnings Call Transcript

AdvanSix (ASIX) reported Q3 2026 sales of $431M, up 15% YoY, driven by pricing. Adjusted EBITDA was $15M, down $10M YoY. Ammonia sales expected to rise 25% for the year. Nylon resin production up 5% YoY. Company focuses on cost reduction, operational excellence, and disciplined capital deployment.

$ASIXHigh

ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release ADVANSIX ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS 3Q26 Sales of $431 million, up 15% versus prior year 3Q26 Earnings Per Share of ($0.28); Adjusted Earnings Per Share of ($0.24) 3Q26 Cash Flow from Operations of $48 million, up $21 million versus p